Memorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025
Advanced Colorectal Cancer Management, Precision Oncology & Multidisciplinary Care
The Memorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025 is a premier multidisciplinary oncology conference dedicated to the latest innovations in the diagnosis, treatment, and management of colorectal malignancies. Hosted by one of the world’s leading cancer centers, this comprehensive two-day symposium brings together internationally recognized experts in medical oncology, surgical oncology, radiation oncology, gastroenterology, pathology, and interventional radiology to discuss cutting-edge developments that are transforming colorectal cancer care.
The program provides in-depth coverage of both localized and metastatic colorectal cancer, highlighting emerging treatment strategies, precision oncology, molecular profiling, immunotherapy advances, organ-preservation approaches, and novel targeted therapies. Participants gain practical insights through expert lectures, live surgical demonstrations, multidisciplinary tumor boards, and evidence-based discussions focused on optimizing patient outcomes.
Particular emphasis is placed on evolving management paradigms in rectal cancer, including Total Neoadjuvant Therapy (TNT), Watch-and-Wait strategies, metastatic disease management, KRAS and BRAF targeted therapies, and the integration of personalized treatment approaches into modern oncology practice.
Product Details
- Format: 21 Videos + 21 PDF Presentations
- Total Size: 8.04 GB
- Course Dates: November 6–7, 2025
- Location: Zuckerman Research Center, Memorial Sloan Kettering Cancer Center, New York, NY
- Access: On-Demand
- Level: Advanced
Program Overview
Colorectal cancer remains one of the most common and complex malignancies worldwide. Rapid advances in molecular diagnostics, targeted therapies, surgical techniques, and multidisciplinary care have significantly improved patient outcomes while creating new challenges in treatment selection and sequencing.
This conference provides comprehensive updates on:
- Colon cancer
- Rectal cancer
- Anal cancer
- Metastatic colorectal cancer
- Precision oncology
- Molecular profiling
- Immunotherapy
- Targeted therapies
- Total Neoadjuvant Therapy (TNT)
- Watch-and-Wait protocols
- Organ preservation strategies
- Surgical innovations
- Multidisciplinary cancer care
The curriculum focuses on translating emerging evidence into practical clinical decision-making.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Develop effective multidisciplinary colorectal cancer treatment programs.
- Evaluate surgical options for complex rectal cancer cases.
- Identify appropriate candidates for Watch-and-Wait strategies.
- Apply evidence-based treatment recommendations for metastatic colorectal cancer.
- Integrate targeted therapies based on molecular tumor profiling.
- Assess advancements in immunotherapy for colorectal malignancies.
- Interpret recent clinical trial data and apply findings to practice.
- Optimize patient outcomes through coordinated multidisciplinary care.
Core Topics Covered
Rectal Cancer Management
A major focus of the symposium is contemporary rectal cancer care.
Topics include:
- Total Neoadjuvant Therapy (TNT)
- Organ preservation strategies
- Watch-and-Wait protocols
- Locally advanced rectal cancer
- Surgical decision-making
- Functional outcomes
- Treatment sequencing
Faculty discuss current controversies and evolving standards of care.
Multidisciplinary Colorectal Cancer Care
The conference emphasizes collaborative treatment planning involving:
- Medical oncology
- Radiation oncology
- Surgical oncology
- Gastroenterology
- Pathology
- Interventional radiology
Participants learn how multidisciplinary programs improve treatment coordination and patient outcomes.
Metastatic Colorectal Cancer
Sessions review modern management strategies for advanced disease, including:
- Systemic therapy selection
- Liver metastases management
- Lung metastases treatment
- Conversion therapy
- Surgical resection strategies
- Ablative interventions
- Long-term surveillance
Experts highlight individualized approaches to metastatic disease.
Precision Oncology & Molecular Profiling
The program explores advances in personalized cancer therapy including:
- KRAS-targeted therapies
- BRAF-targeted therapies
- Biomarker-driven treatment
- Molecular testing strategies
- Genomic profiling
- Precision treatment selection
Participants gain updates on rapidly evolving molecular oncology applications.
Immunotherapy in Colorectal Cancer
Dedicated sessions cover:
- MSI-H colorectal cancer
- Checkpoint inhibitors
- Immunotherapy combinations
- Resistance mechanisms
- Emerging immunotherapeutic approaches
Faculty review current evidence and future directions.
Surgical Oncology Updates
Participants receive advanced instruction on:
- Distal rectal cancer surgery
- Minimally invasive approaches
- Complex pelvic surgery
- Organ preservation
- Surgical innovations
- Technical considerations
Live surgical demonstrations provide practical learning opportunities.
Clinical Trial Reviews
Experts analyze recent landmark studies involving:
- Colon cancer
- Rectal cancer
- Anal cancer
- Targeted therapies
- Immunotherapy
- Neoadjuvant strategies
The conference helps clinicians translate new evidence into clinical practice.
Interactive Tumor Boards
A hallmark of the symposium includes multidisciplinary tumor board discussions featuring:
- Challenging colorectal cancer cases
- Complex treatment decisions
- Imaging interpretation
- Surgical planning
- Personalized treatment approaches
These sessions provide real-world clinical insights and collaborative problem-solving.
Educational Features
✔ Live Surgical Demonstrations
✔ Multidisciplinary Tumor Boards
✔ Precision Oncology Updates
✔ KRAS & BRAF Targeted Therapy Reviews
✔ Immunotherapy Advances
✔ TNT & Watch-and-Wait Discussions
✔ Metastatic Disease Management
✔ Evidence-Based Clinical Trial Analysis
Target Audience
This course is ideal for:
- Medical Oncologists
- Radiation Oncologists
- Colorectal Surgeons
- Surgical Oncologists
- Hepatopancreatobiliary Surgeons
- Gastroenterologists
- Pathologists
- Surgical Pathologists
- Interventional Radiologists
- Oncology Fellows
- Advanced Practice Providers
- Multidisciplinary Oncology Teams
Why This Course Stands Out
✔ Hosted by Memorial Sloan Kettering Cancer Center
✔ Comprehensive focus on colorectal malignancies
✔ Live surgery broadcasts from operating rooms
✔ Strong emphasis on multidisciplinary collaboration
✔ Coverage of emerging molecular and targeted therapies
✔ Practical application of TNT and Watch-and-Wait strategies
✔ Interactive tumor board case discussions
✔ Reviews latest evidence shaping colorectal cancer care
Clinical & Educational Value
The Memorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025 delivers a state-of-the-art review of modern colorectal cancer management. Through comprehensive coverage of precision oncology, advanced surgical techniques, immunotherapy, targeted treatments, and multidisciplinary care models, the program equips clinicians with the knowledge and clinical strategies necessary to optimize outcomes for patients with colorectal malignancies.
+ Topics:
Thursday, November 6, 2025
Only PDFs and videos consented to by faculty are available below. Multidisciplinary Tumor Boards will not be posted on the online syllabus.
- 1:30PM – 1:45PM
- Patricia Sylla, MD, FACS, FASCRS
- 1:45PM – 2:00PM
- Martin R. Weiser, MD
- 2:00PM – 2:15PM
- Emmanouil Pappou, MD,PhD
- 2:15PM – 2:30PM
- Geerard Beets, MD, PhD, Professor of Surgical Oncology
- 2:30PM – 2:45PM
- Abraham J. J Wu, MD
- 2:45PM – 3:15PM
- Georgios Karagkounis, MD (Moderator)
- Iris H. Wei, MD (Moderator)
Friday, November 7, 2025
The Harbinger’s Dilemma: ctDNA in Colorectal Cancer
- 8:05AM – 9:00AM
- Scott Kopetz, MD, PhD
Management Options for Intermediate Risk Mid Rectal Cancer
- 9:00AM – 9:25AM
- Leonard B Saltz, MD
- Jurriaan Tuynman, MD, PhD
- Neoadjuvant Therapy for Everyone — Leonard Saltz, MDNeoadjuvant Therapy is Rarely Neccesary — Jurriaan Tuynman, MD, PhD
- 9:25AM – 9:50AM
- Maria Widmar, MD, Assistant Attending
- Iris H. Wei, MD
- Surgery Now — Iris H. Wei, MD, FACSNo Need to Rush to the OR — Maria Widmar, MD, MPH
- 9:50AM – 10:15AM
- Alessandro Fichera, MD, FACS, FASCRS, FISS, FCCF
- Anwaar Saeed, MD
- Pro — Anwaar Saeed, MDCon — Alessandro Fichera, MD
- 10:15AM – 10:40AM
- Vinod Balachandran, MD, Associate Member
- Kai-Keen Shiu, MBBS, PhD, FRCP
- Immune Checkpoint Blockade in pMMR Colon and Rectal Cancer — Kai-Keen Shiu, PhD, FRCPmRNA Vaccines — Vinod P. Balachandran, MD (Please note, slides are not
- available for this presentation)
- 11:00AM – 11:15AM
- Jessica Scott, PhD
- 11:15AM – 11:30AM
- Luis Diaz Jr., MD
- 11:30AM – 11:45AM
- Karuna Ganesh, MD
- 11:45AM – 12:00PM
- Rona Yaeger, MD
- 12:00PM – 12:15PM
- Michael Foote, MD
- 12:15PM – 12:30PM
- Andrew T Chan, MD, MPH
- 1:30PM – 2:00PM
- Geerard Beets, MD, PhD, Professor of Surgical Oncology (Panelist)
- Qingyang Feng, MD, Associate Professor (Presenter)
- 2:00PM – 2:30PM
- Martin R. Weiser, MD (Panelist)
- Jurriaan Tuynman, MD, PhD (Presenter)
- 2:30PM – 3:00PM
- Neil H. H Segal, MD, PhD (Panelist)
- Anwaar Saeed, MD (Presenter)
Pod1um 303
- 3:00PM – 3:30PM
- Maliha Nusrat, MBBS (Panelist)
- Sheela Rao, MBBS, MD, FRCP, Consultant Medical Oncologist, Reader in Gastrointestinal Cancers (Presenter)








